- Home
- ADX vs LIVN Comparison
ADX vs LIVN Comparison
Compare ADX & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADX
- LIVN
- Stock Information
- Founded
- ADX 1840
- LIVN 1987
- Country
- ADX United States
- LIVN United Kingdom
- Employees
- ADX N/A
- LIVN N/A
- Industry
- ADX Investment Managers
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADX Finance
- LIVN Health Care
- Exchange
- ADX Nasdaq
- LIVN Nasdaq
- Market Cap
- ADX 2.3B
- LIVN 2.2B
- IPO Year
- ADX N/A
- LIVN 1993
- Fundamental
- Price
- ADX $18.93
- LIVN $39.13
- Analyst Decision
- ADX
- LIVN Buy
- Analyst Count
- ADX 0
- LIVN 7
- Target Price
- ADX N/A
- LIVN $60.29
- AVG Volume (30 Days)
- ADX 182.4K
- LIVN 758.6K
- Earning Date
- ADX 01-01-0001
- LIVN 05-07-2025
- Dividend Yield
- ADX 6.68%
- LIVN N/A
- EPS Growth
- ADX N/A
- LIVN 262.50
- EPS
- ADX N/A
- LIVN 1.16
- Revenue
- ADX N/A
- LIVN $1,253,437,000.00
- Revenue This Year
- ADX N/A
- LIVN $5.47
- Revenue Next Year
- ADX N/A
- LIVN $5.30
- P/E Ratio
- ADX N/A
- LIVN $33.73
- Revenue Growth
- ADX N/A
- LIVN 8.66
- 52 Week Low
- ADX $14.94
- LIVN $36.85
- 52 Week High
- ADX $19.57
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- ADX 38.20
- LIVN 38.77
- Support Level
- ADX $18.86
- LIVN $39.16
- Resistance Level
- ADX $19.52
- LIVN $40.30
- Average True Range (ATR)
- ADX 0.30
- LIVN 1.09
- MACD
- ADX 0.06
- LIVN 0.25
- Stochastic Oscillator
- ADX 39.18
- LIVN 44.59
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally-managed closed-end fund. The investment objectives of the company are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It has a diversified equity portfolio which consists of securities of companies from Energy, Consumer Staples, Information Technology, Financials and other sectors.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.